|
NCRNA00120 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.90210000048519E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.65979999997312E-06 |
| Normal-vs-Stage2 |
1.42670000258249E-08 |
| Normal-vs-Stage3 |
5.56950000007994E-07 |
| Normal-vs-Stage4 |
9.87770000000499E-05 |
| Stage1-vs-Stage2 |
3.216000E-03 |
| Stage1-vs-Stage3 |
1.690820E-01 |
| Stage1-vs-Stage4 |
9.545000E-01 |
| Stage2-vs-Stage3 |
1.553050E-01 |
| Stage2-vs-Stage4 |
4.360000E-02 |
| Stage3-vs-Stage4 |
3.794800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21509999998037E-06 |
| Normal-vs-AfricanAmerican |
1.185820E-02 |
| Normal-vs-Asian |
2.08849999999705E-05 |
| Caucasian-vs-AfricanAmerican |
3.544800E-01 |
| Caucasian-vs-Asian |
7.779200E-01 |
| AfricanAmerican-vs-Asian |
3.221800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.48039999983796E-07 |
| Normal-vs-Female |
2.16590000001737E-06 |
| Male-vs-Female |
1.456010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.017950E-04 |
| Normal-vs-Age(41-60Yrs) |
7.1425000025549E-08 |
| Normal-vs-Age(61-80Yrs) |
1.11869999996905E-06 |
| Normal-vs-Age(81-100Yrs) |
6.235900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.703150E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.192100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.084400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.998800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.913200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.604200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.905400E-01 |
| Classical-VS-Follicular |
9.97179999999709E-05 |
| Classical-VS-Other |
8.861200E-01 |
| Classical-VS-Normal |
4.02940000000518E-05 |
| Tall-VS-Follicular |
1.492160E-01 |
| Tall-VS-Other |
6.662000E-01 |
| Tall-VS-Normal |
1.84072999999119E-05 |
| Follicular-VS-Other |
2.387200E-01 |
| Follicular-VS-Normal |
1.21790000306987E-08 |
| Other-VS-Normal |
7.438400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52609999970466E-07 |
| Normal-vs-N1 |
4.06780000000717E-05 |
| N0-vs-N1 |
3.289600E-01 |
|
|
